Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

The outcome of patients with multiple myeloma is dictated primarily by cytogenetic abnormalities and proliferative capacity of plasma cells. We studied the outcome after initial therapy with lenalidomide-dexamethasone among 100 newly diagnosed patients, risk-stratified by genetic abnormalities and p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kapoor, Prashant, Kumar, Shaji, Fonseca, Rafael, Lacy, Martha Q., Witzig, Thomas E., Hayman, Suzanne R., Dispenzieri, Angela, Buadi, Francis, Bergsagel, P. Leif, Gertz, Morie A., Dalton, Robert J., Mikhael, Joseph R., Dingli, David, Reeder, Craig B., Lust, John A., Russell, Stephen J., Roy, Vivek, Zeldenrust, Steven R., Stewart, A. Keith, Kyle, Robert A., Greipp, Philip R., Rajkumar, S. Vincent
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713462/
https://ncbi.nlm.nih.gov/pubmed/19324902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-01-202010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados